MIRIKIZUMAB THERAPY IS ASSOCIATED WITH IMPROVED FATIGUE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE

Miguel Regueiro  1     Monika Fischer  2     David T. Rubin  3     Mingyang Shan  4     Deanilee Deckard     Paul Pollack     Theresa Hunter Gibble     Lai Shan Chan     Pieter Hindryckx  5    
1 Cleveland Clinic Main Campus, Cleveland, United States
2 Indiana University, Indianapolis, United States
3 University of Chicago Medicine, Chicago, United States
4 Eli Lilly and Company, Indianapolis, United States
5 Hospital of Ghent, Ghent, Belgium

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing